Source Date | Board Meeting Date | Details |
16-Oct-2024
|
24-Oct-2024
|
Quarterly Results
|
04-Sep-2024
|
09-Sep-2024
|
Inter alia, to consider and approve issuance of Non ? Convertible Debentures up to INR 2,500 Crore (Rupees Two Thousand Five Hundred Crore Only) on Private Placement Basis, in tranches over the next six months.
|
16-Jul-2024
|
25-Jul-2024
|
Quarterly Results
|
12-Jun-2024
|
18-Jun-2024
|
Inter alia, to consider and approve:- Fund raising by issuance of Non-Convertible Debentures (NCDs) aggregating up to INR 10,000 Crore (Rupees Ten Thousand Crore Only) on private placement basis in one or more tranches is being placed for consideration/review by the Board and for obtaining approval from the shareholders at the ensuing Annual General meeting of the Company.
|
15-Apr-2024
|
29-Apr-2024
|
Quarterly Results & Audited Results
|
15-Jan-2024
|
24-Jan-2024
|
Quarterly Results
|
16-Nov-2023
|
24-Nov-2023
|
Inter alia, to consider and approve issuance of Non ? Convertible Debentures up to INR 3,500 Crore (Rupees Three Thousand Five Hundred Crore Only) on Private Placement Basis, in tranches over the next six months.
|
09-Oct-2023
|
23-Oct-2023
|
Quarterly Results
|
13-Jul-2023
|
24-Jul-2023
|
Quarterly Results
|
19-Jun-2023
|
22-Jun-2023
|
Inter alia to consider and approve issuance of Non ? Convertible Debentures aggregating up to INR 5,000 Crore (Rupees Five Thousand Crore Only) on Private Placement Basis.
|
09-May-2023
|
18-May-2023
|
Quarterly Results & Audited Results
|
23-Mar-2023
|
28-Mar-2023
|
Right Issue of Equity Shares
|
16-Jan-2023
|
24-Jan-2023
|
Quarterly Results
|
17-Oct-2022
|
27-Oct-2022
|
Quarterly Results
|
18-Jul-2022
|
28-Jul-2022
|
Quarterly Results
|
07-Jun-2022
|
14-Jun-2022
|
Inter alia to consider and approve issuance of Non ? Convertible Debentures aggregating up to INR 2,000 Crore (Rupees Two Thousand Crore Only) on Private Placement Basis.
|
13-Apr-2022
|
28-Apr-2022
|
Audited Results & Quarterly Results
|
04-Mar-2022
|
09-Mar-2022
|
Inter alia, to consider fund raising options by issue of equity shares through appropriate methods (including Rights Issue), subject to requisite approvals as required under applicable law
|
10-Jan-2022
|
20-Jan-2022
|
Quarterly Results
|
20-Oct-2021
|
02-Nov-2021
|
Quarterly Results
|